Drug use disorders, particularly when untreated, increase morbidity and mortality risks for individuals, can trigger substantial suffering and lead to impairment in personal, family, social, educational, occupational or other important. It covers systemic antifungal drugs in development worldwide, including label extension and repurposed products, and critically evaluates how well the current pipeline addresses infections caused by who fungal priority pathogens. About who drug information who drug information is a quarterly journal providing an overview of topics relating to medicines development and regulation which is targeted to a wide audience of health professionals and policy makers
Pictures of Kirsten Price
Launched in 1987, who drug information communicates the latest international news and trends to regulatory agencies, academic and training institutions, researchers.
Access to appropriate medications is shown to have substantial impacts on community health and the related economic indicators
In the anatomical therapeutic chemical (atc) classification system, the active substances are divided into different groups according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties Drugs are classified in groups at five different levels. Drug consumption can be expressed in cost, number of units, number of prescriptions or by the physical quantity of drugs However these variables can vary between regions and countries over time
This limits comparisons of drug consumption at an international level To address this, a technical unit of measurement, the defined daily dose (ddd) was created. This report presents the first world health organization (who) analysis of antifungal agents in preclinical and clinical development
